1Department of Internal Medicine, Beaumont Hospital, Dearborn, MI
2Division of Hematology & Oncology, Internal Medicine Department, Beaumont Hospital, Dearborn, MI
American Journal of Medical Case Reports.
2021,
Vol. 9 No. 8, 394-396
DOI: 10.12691/ajmcr-9-8-3
Copyright © 2021 Science and Education PublishingCite this paper: Hafsa Parpia, Eman EL-Sawalhy, Maher Khadra, Raisa Mayers, Samyuktha Madishetty, Faisal Musa. Immune Thrombocytopenic Pupura after COVID-19 Vaccine, a Case Report.
American Journal of Medical Case Reports. 2021; 9(8):394-396. doi: 10.12691/ajmcr-9-8-3.
Correspondence to: Eman EL-Sawalhy, Department of Internal Medicine, Beaumont Hospital, Dearborn, MI. Email:
Eman.Elsawalhy@beaumont.orgAbstract
Immune Thrombocytopenic Purpura (ITP) is an autoimmune disorder caused by different entities, one of them being the administration of certain vaccines, most commonly MMR vaccines that have been linked with the development of this disease. We report a 26-year-old female presented to the hospital with a petechial rash and mucosal bleeding after three weeks of administration of the COVID-19 vaccine. Thrombocytopenia workup was done, ITP was diagnosed. The ITP in this case was refractory to initial treatment of IVIG and steroid. Rituximab was initiated and she had an excellent response to it.
Keywords